NDC 17156-235

AdreView

Iobenguane I-123

AdreView is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Medi-physics Inc.. The primary component is Iobenguane I-123.

Product ID17156-235_0b572d19-1394-4123-9c7b-0b7cbfc5c79d
NDC17156-235
Product TypeHuman Prescription Drug
Proprietary NameAdreView
Generic NameIobenguane I-123
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2008-09-19
Marketing CategoryNDA / NDA
Application NumberNDA022290
Labeler NameMedi-Physics Inc.
Substance NameIOBENGUANE I-123
Active Ingredient Strength2 mCi/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 17156-235-01

1 VIAL, GLASS in 1 CONTAINER (17156-235-01) > 5 mL in 1 VIAL, GLASS
Marketing Start Date2008-09-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17156-235-01 [17156023501]

AdreView INJECTION
Marketing CategoryNDA
Application NumberNDA022290
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2008-09-19

Drug Details

Active Ingredients

IngredientStrength
IOBENGUANE I-1232 mCi/mL

OpenFDA Data

SPL SET ID:c89d3ecc-4f4c-4566-8808-79152344194d
Manufacturer
UNII

Trademark Results [AdreView]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ADREVIEW
ADREVIEW
78318112 3014913 Live/Registered
GE HEALTHCARE LIMITED
2003-10-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.